title: Topotecan continuous infusion: CA-125 responses including patients pretreated with other schedules of topotecan.
authors.forename: Franco
authors.initials: F
authors.lastname: Muggia
authors.forename: Rebecca
authors.initials: R
authors.lastname: Kosloff
authors.forename: Leonard
authors.initials: L
authors.lastname: Liebes
authors.forename: Howard
authors.initials: H
authors.lastname: Hochster
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018394:CA-125 Antigen / Q000097:blood*; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D019772:Topotecan / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D018394:CA-125 Antigen; D019772:Topotecan